TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Andlauer Healthcare Group ( (TSE:AND) ).
Andlauer Healthcare Group reported a decrease in revenue for Q2 2025, primarily due to challenges in its US-based truckload businesses and the deconsolidation of a packaging subsidiary. Despite these challenges, the company maintained its EBITDA margin within the target range. The company is set to be acquired by UPS in an all-cash transaction valued at approximately $2.2 billion, with the transaction expected to close in the second half of the year, pending regulatory approval.
The most recent analyst rating on (TSE:AND) stock is a Hold with a C$42.00 price target. To see the full list of analyst forecasts on Andlauer Healthcare Group stock, see the TSE:AND Stock Forecast page.
Spark’s Take on TSE:AND Stock
According to Spark, TipRanks’ AI Analyst, TSE:AND is a Outperform.
Andlauer Healthcare Group’s strong financial performance and the positive impact of the UPS acquisition drive the stock’s score. While technical indicators suggest a neutral trend, the overvaluation concerns temper the overall outlook.
To see Spark’s full report on TSE:AND stock, click here.
More about Andlauer Healthcare Group
Andlauer Healthcare Group Inc. operates within the healthcare logistics and specialized transportation industry, offering services such as logistics and distribution, ground transportation, air freight forwarding, and dedicated last mile delivery. The company focuses on the Canadian market with some operations in the US, particularly in truckload businesses.
Average Trading Volume: 95,154
Technical Sentiment Signal: Buy
Current Market Cap: C$2.08B
See more insights into AND stock on TipRanks’ Stock Analysis page.